Medical Supply Chain Emergency Act of 2020
Latest action · Mar 25, 2020 Referred to the House Committee on Financial Services.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 25, 2020
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Medical Supply Chain Emergency Act of 2020
This bill directs the President to use existing authorities under the Defense Production Act of 1950 with respect to the production of ventilators, N-95 respirator masks, and specified personal protective equipment to address COVID-19 (i.e., coronavirus disease 2019). (That act confers upon the President a broad set of authorities to influence domestic industry in order to provide essential materials and goods needed for the national defense.)
The President must (1) make a determination that such items are essential for the national defense, (2) identify private-sector capacity to produce these items, and (3) exercise authorities under the act to require emergency production of them at a reasonable price. In addition, the President shall coordinate the allocation of these items based on requests from governors and the needs of the states as determined by the number of COVID-19 cases and the proportion of the population at higher risk of the disease in a given state.
The bill makes specified funds available for these efforts. Equipment produced under these authorities but unused at the termination of the COVID-19 emergency declared on March 13, 2020, shall be deposited into the Strategic National Stockpile.
Cosponsors 123
Members who signed on, in the order they did. Signatures ran from Mar 25, 2020 to May 27, 2020; 65 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-VA | Abigail Davis Spanberger | Original | Mar 25, 2020 |
| D-CA | Adam B. Schiff | Original | Mar 25, 2020 |
| D-NJ | Albio Sires | Original | Mar 25, 2020 |
| D-FL | Alcee L. Hastings | Original | Mar 25, 2020 |
| D-NJ | Andy Kim | Original | Mar 25, 2020 |
| D-MN | Angie Craig | Original | Mar 25, 2020 |
| D-NH | Ann M. Kuster | Original | Mar 25, 2020 |
| D-CA | Anna G. Eshoo | Original | Mar 25, 2020 |
| D-MD | Anthony G. Brown | Original | Mar 25, 2020 |
| D-MA | Ayanna Pressley | Original | Mar 25, 2020 |
| D-CA | Barbara Lee | Original | Mar 25, 2020 |
| D-NM | Ben Ray Luján | Original | Mar 25, 2020 |
| D-MS | Bennie G. Thompson | Original | Mar 25, 2020 |
| D-IL | Bobby L. Rush | Original | Mar 25, 2020 |
| D-NJ | Bonnie Watson Coleman | Original | Mar 25, 2020 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Financial Services Committee | Referred Mar 25, 2020 |
Actions 2
Everything that happened, newest first.
- Mar 25, 2020Introduced in House
- Mar 25, 2020Referred to the House Committee on Financial Services.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 166, no. 59, March 25, 2020, page H1726.
CRS reports 3
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 3
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R46304 | COVID-19: China Medical Supply Chains and Broader Trade Issues | Report | Dec 23, 2020 |
| R46507 | FDA’s Role in the Medical Product Supply Chain and Considerations During COVID-19 Archived | Report | Sep 1, 2020 |
| R46319 | Novel Coronavirus 2019 (COVID-19): Q&A on Global Implications and Responses Archived | Report | May 14, 2020 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 3568 | Medical Supply Chain Emergency Act of 2020 | Identical bill | Mar 23, 2020 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To require the President to use authorities under the Defense Production Act of 1950 to require emergency production of medical equipment to address the COVID-19 outbreak.
- Short Title(s) as Introduced
- Medical Supply Chain Emergency Act of 2020
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Cardiovascular and respiratory health
- Emergency medical services and trauma care
- Health
- Health personnel
- Health programs administration and funding
- Health technology, devices, supplies
- Infectious and parasitic diseases
- Military procurement, research, weapons development
- Public contracts and procurement
- Strategic materials and reserves
- Worker safety and health
Text 1
Each version as it was printed, newest first.
- Mar 25, 2020Introduced in House
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.